NRNP 6675 Assignment 1: Evaluation and Management (E/M)

NRNP 6675 Assignment 1: Evaluation and Management (E/M)

 

To Prepare

  • Review this week’s Learning Resources on coding, billing, reimbursement.
  • Review the E/M patient case scenario provided.

The Assignment

  • Assign DSM-5 and ICD-10 codes to services based upon the patient case scenario.
  • Then, in 1–2 pages address the following. You may add your narrative answers to these questions to the bottom of the case scenario document and submit them all together as one document.
  • Explain what pertinent information, generally, is required in documentation to support DSM-5 and ICD-10 coding.
  • Explain what pertinent documentation is missing from the case scenario, and what other information would be helpful to narrow your coding and billing options.
  • Finally, explain how to improve documentation to support coding and billing for maximum reimbursement.
NRNP 6675 Evaluation and Management
NRNP 6675 Evaluation and Management

ORDER A NRNP 6675 Evaluation and Management PAPER TODAY !!

We will write
a custom nursing essay or paper
specifically for you
Get your first paper with
15% OFF

Learning Resources

 

Required/ Optional Readings (click to expand/reduce)

American Psychiatric Association. (2020). Updates to DSM–5 criteria, text, and ICD-10 codes. https://www.psychiatry.org/psychiatrists/practice/dsm/updates-to-dsm-5

American Psychiatric Association. (2013). Insurance implications of DSM-5. https://www.psychiatry.org/File%20Library/Psychiatrists/Practice/DSM/APA_DSM_Insurance-Implications-of-DSM-5.pdf

Clicking on this link will initiate the download of the PDF.

American Psychiatric Association. (2020). Coding and reimbursement.

https://www.psychiatry.org/psychiatrists/practice/practice-management/coding-reimbursement-medicare-and-medicaid/coding-and-reimbursement

American Psychiatric Association. (2013). Numerical listing of DSM-5 diagnoses and codes (ICD-10-CM). In Diagnostic and statistical manual of mental disorders (5th ed.). http://dsm.psychiatryonline.org.ezp.waldenulibrary.org/doi/10.1176/appi.books.9780890425596.ICD10Num_list

Buppert, C. (2021). Nurse practitioner’s business practice and legal guide (7th ed.). Jones & Bartlett Learning.

Chapter 9, “Reimbursement for Nurse Practitioner Services”

Centers for Medicare & Medicaid Services. (2020). Your billing responsibilities. https://www.cms.gov/Medicare/Coordination-of-Benefits-and-Recovery/ProviderServices/Your-Billing-Responsibilities

Stewart, J. G., & DeNisco, S. M. (2019). Role development for the nurse practitioner (2nd ed.). Jones & Bartlett Learning.

Chapter 15, “Reimbursement for Nurse Practitioner Services”

Walden University Academic Skills Center. (2017). Developing SMART goals. https://academicguides.waldenu.edu/ld.php?content_id=51901492

Zakhari, R. (2021). The psychiatric-mental health nurse practitioner certification review manual. Springer Publishing Company.

Chapter 4 “Neuroanatomy, Physiology, and Mental Illness”

Document: E/M Patient Case Study

Patient Scenario

Instructions

  Use the following case template to complete Week 2 Assignment 1. On page 5, assign DSM-5 and ICD-10 codes to the services documented. You will add your narrative answers to the assignment questions to the bottom of this template and submit them altogether as one document.

Identifying Information

Identification was verified by stating of their name and date of birth.

Time spent for evaluation: 0900am-0957am

Chief Complaint

“My other provider retired. I don’t think I’m doing so well.”

HPI

 

25 yo Russian female evaluated for psychiatric evaluation referred from her retiring practitioner for PTSD, ADHD, Stimulant Use Disorder, in remission. She is currently prescribed fluoxetine 20mg po daily for PTSD, atomoxetine 80mg po daily for ADHD.

Today, client denied symptoms of depression, denied anergia, anhedonia, amotivation, no anxiety, denied frequent worry, reports feeling restlessness, no reported panic symptoms, no reported obsessive/compulsive behaviors. Client denies active SI/HI ideations, plans or intent. There is no evidence of psychosis or delusional thinking.

Client denied past episodes of hypomania, hyperactivity, erratic/excessive spending, involvement in dangerous activities, self-inflated ego, grandiosity, or promiscuity. Client reports increased irritability and easily frustrated, loses things easily, makes mistakes, hard time focusing and concentrating, affecting her job. Has low frustration tolerance, sleeping 5–6 hrs/24hrs reports nightmares of previous rape, isolates, fearful to go outside, has missed several days of work, appetite decreased.

She has somatic concerns with GI upset and headaches. Client denied any current binging/purging behaviors, denied withholding food from self or engaging in anorexic behaviors. No self-mutilation behaviors.

 

Diagnostic Screening Results

Screen of symptoms in the past 2 weeks:

PHQ 9 = 0 with symptoms rated as no difficulty in functioning
Interpretation of Total Score
Total Score Depression Severity 1-4 Minimal depression 5-9 Mild depression 10-14 Moderate depression 15-19 Moderately severe depression 20-27 Severe depression

GAD 7 = 2 with symptoms rated as no difficulty in functioning
Interpreting the Total Score:
Total Score Interpretation ≥10 Possible diagnosis of GAD; confirm by further evaluation 5 Mild Anxiety 10 Moderate anxiety 15 Severe anxiety

MDQ screen negative

PCL-5 Screen 32

Past Psychiatric and Substance Use Treatment

  • Entered mental health system when she was age 19 after raped by a stranger during a house burglary.
  • Previous Psychiatric Hospitalizations:  denied
  • Previous Detox/Residential treatments: one for abuse of stimulants and cocaine in 2015
  • Previous psychotropic medication trials: sertraline (became suicidal), trazodone (worsened nightmares), bupropion (became suicidal), Adderall (began abusing)
  • Previous mental health diagnosis per client/medical record: GAD, Unspecified Trauma, PTSD, Stimulant use disorder, ADHD confirmed by school records

Substance Use History

Have you used/abused any of the following (include frequency/amt/last use):

Substance Y/N Frequency/Last Use
Tobacco products Y ½
ETOH Y last drink 2 weeks ago, reports drinks 1-2 times monthly one drink socially
Cannabis N
Cocaine Y last use 2015
Prescription stimulants Y last use 2015
Methamphetamine N
Inhalants N
Sedative/sleeping pills N
Hallucinogens N
Street Opioids N
Prescription opioids N
Other: specify (spice, K2, bath salts, etc.) Y reports one-time ecstasy use in 2015

 

Any history of substance related:

  • Blackouts:  +
  • Tremors:   –
  • DUI: –
  • D/T’s: –
  • Seizures: –

Longest sobriety reported since 2015—stayed sober maintaining sponsor, sober friends, and meetings

Psychosocial History

Client was raised by adoptive parents since age 6; from Russian orphanage. She has unknown siblings. She is single; has no children.

Employed at local tanning bed salon

Education: High School Diploma

Denied current legal issues.

Suicide / HOmicide Risk Assessment

RISK FACTORS FOR SUICIDE:

  • Suicidal Ideas or plans – no
  • Suicide gestures in past – no
  • Psychiatric diagnosis – yes
  • Physical Illness (chronic, medical) – no
  • Childhood trauma – yes
  • Cognition not intact – no
  • Support system – yes
  • Unemployment – no
  • Stressful life events – yes
  • Physical abuse – yes
  • Sexual abuse – yes
  • Family history of suicide – unknown
  • Family history of mental illness – unknown
  • Hopelessness – no
  • Gender – female
  • Marital status – single
  • White race
  • Access to means
  • Substance abuse – in remission

 

PROTECTIVE FACTORS FOR SUICIDE:

  • Absence of psychosis – yes
  • Access to adequate health care – yes
  • Advice & help seeking – yes
  • Resourcefulness/Survival skills – yes
  • Children – no
  • Sense of responsibility – yes
  • Pregnancy – no; last menses one week ago, has Norplant
  • Spirituality – yes
  • Life satisfaction – “fair amount”
  • Positive coping skills – yes
  • Positive social support – yes
  • Positive therapeutic relationship – yes
  • Future oriented – yes

 

Suicide Inquiry: Denies active suicidal ideations, intentions, or plans. Denies recent self-harm behavior. Talks futuristically. Denied history of suicidal/homicidal ideation/gestures; denied history of self-mutilation behaviors

Global Suicide Risk Assessment: The client is found to be at low risk of suicide or violence, however, risk of lethality increased under context of drugs/alcohol.

No required SAFETY PLAN related to low risk

Mental Status Examination

She is a 25 yo Russian female who looks her stated age. She is cooperative with examiner. She is neatly groomed and clean, dressed appropriately. There is mild psychomotor restlessness. Her speech is clear, coherent, normal in volume and tone, has strong cultural accent. Her thought process is ruminative. There is no evidence of looseness of association or flight of ideas. Her mood is anxious, mildly irritable, and her affect appropriate to her mood. She was smiling at times in an appropriate manner. She denies any auditory or visual hallucinations. There is no evidence of any delusional thinking. She denies any current suicidal or homicidal ideation. Cognitively, She is alert and oriented to all spheres. Her recent and remote memory is intact. Her concentration is fair. Her insight is good.

Clinical Impression

Client is a 25 yo Russian female who presents with history of treatment for PTSD, ADHD, Stimulant use Disorder, in remission.

Moods are anxious and irritable. She has ongoing reported symptoms of re-experiencing, avoidance, and hyperarousal of her past trauma experiences; ongoing subsyndromal symptoms related to her past ADHD diagnosis and exacerbated by her PTSD diagnosis. She denied vegetative symptoms of depression, no evident mania/hypomania, no psychosis, denied anxiety symptoms. Denied current cravings for drugs/alcohol, exhibits no withdrawal symptoms, has somatic concerns of GI upset and headaches.

At the time of disposition, the client adamantly denies SI/HI ideations, plans or intent and has the ability to determine right from wrong, and can anticipate the potential consequences of behaviors and actions. She is a low risk for self-harm based on her current clinical presentation and her risk and protective factors.

Diagnostic Impression

[Student to provide DSM-5 and ICD-10 coding]

 

Double click inside this text box to add/edit text. Delete placeholder text when you add your answers.

Treatment Plan

1) Medication:

  • Increase fluoxetine 40mg po daily for PTSD #30 1 RF
  • Continue with atomoxetine 80mg po daily for ADHD.  #30 1 RF

Instructed to call and report any adverse reactions.

Future Plan: monitor for decrease re-experiencing, hyperarousal, and avoidance symptoms; monitor for improved concentration, less mistakes, less forgetful

 

2) Education: Risks and benefits of medications are discussed including non-treatment. Potential side effects of medications discussed. Verbal informed consent obtained.

Not to drive or operate dangerous machinery if feeling sedated.

Not to stop medication abruptly without discussing with providers.

Discussed risks of mixing  medications with OTC drugs, herbal, alcohol/illegal drugs. Instructed to avoid this practice. Praised and Encouraged ongoing abstinence. Maintain support system, sponsors, and meetings.

Discussed how drugs/ETOH affects mental health, physical health, sleep architecture.

 

3)       Patient was educated about therapy and services of the MHC including emergent care. Referral was sent via email to therapy team for PET treatment.

 

4)       Patient has emergency numbers: Emergency Services 911, the national Crisis Line 800-273-TALK, the MHC Crisis Clinic. Patient was instructed to go to nearest ER or call 911 if they become actively suicidal and/or homicidal.

 

5)       Time allowed for questions and answers provided. Provided supportive listening. Patient appeared to understand discussion and appears to have capacity for decision making via verbal conversation.

 

6)       RTC in 30 days

 

7)       Follow up with PCP for GI upset and headaches, reviewed PCP history and physical dated one week ago and include lab results

Patient is amenable with this plan and agrees to follow treatment regimen as discussed.

Narrative Answers

 

 

In 1-2 pages, address the following:

  • Explain what pertinent information, generally, is required in documentation to support DSM-5 and ICD-10 coding.
  • Explain what pertinent documentation is missing from the case scenario, and what other information would be helpful to narrow your coding and billing options.
  • Finally, explain how to improve documentation to support coding and billing for maximum reimbursement.

 

Add your answers here. Delete instructions and placeholder text when you add your answers.

 

 

Place your order today!

Psychiatric Patient Evaluation

 

Instructions

  Use the following case template to complete Week 2 Assignment 1. On page 5, assign DSM-5 and ICD-10 codes to the services documented. You will add your narrative answers to the assignment questions to the bottom of this template and submit them altogether as one document.

Identifying Information

Identification was verified by stating of their name and date of birth.

Time spent for evaluation: 0900am-0957am

Chief Complaint

“My other provider retired. I don’t think I’m doing so well.”

HPI

25 yo Russian female evaluated for psychiatric evaluation referred from her retiring practitioner for PTSD, ADHD, Stimulant Use Disorder, in remission. She is currently prescribed fluoxetine 20mg po daily for PTSD, atomoxetine 80mg po daily for ADHD.

Today, client denied symptoms of depression, denied anergia, anhedonia, amotivation, no anxiety, denied frequent worry, reports feeling restlessness, no reported panic symptoms, no reported obsessive/compulsive behaviors. Client denies active SI/HI ideations, plans or intent. There is no evidence of psychosis or delusional thinking.

Client denied past episodes of hypomania, hyperactivity, erratic/excessive spending, involvement in dangerous activities, self-inflated ego, grandiosity, or promiscuity.

Client reports increased irritability and easily frustrated, loses things easily, makes mistakes, hard time focusing and concentrating, affecting her job. Has low frustration tolerance, sleeping 5–6 hrs/24hrs reports nightmares of previous rape, isolates, fearful to go outside, has missed several days of work, appetite decreased. She has somatic concerns with GI upset and headaches.

Client denied any current binging/purging behaviors, denied withholding food from self or engaging in anorexic behaviors. No self-mutilation behaviors.

Diagnostic Screening Results

Screen of symptoms in the past 2 weeks:

PHQ 9 = 0 with symptoms rated as no difficulty in functioning
Interpretation of Total Score
Total Score Depression Severity 1-4 Minimal depression 5-9 Mild depression 10-14 Moderate depression 15-19 Moderately severe depression 20-27 Severe depression

GAD 7 = 2 with symptoms rated as no difficulty in functioning
Interpreting the Total Score:
Total Score Interpretation ≥10 Possible diagnosis of GAD; confirm by further evaluation 5 Mild Anxiety 10 Moderate anxiety 15 Severe anxiety

MDQ screen negative

PCL-5 Screen 32

Past Psychiatric and Substance Use Treatment

  • Entered mental health system when she was age 19 after raped by a stranger during a house burglary.
  • Previous Psychiatric Hospitalizations:  denied
  • Previous Detox/Residential treatments: one for abuse of stimulants and cocaine in 2015
  • Previous psychotropic medication trials: sertraline (became suicidal), trazodone (worsened nightmares), bupropion (became suicidal), Adderall (began abusing)
  • Previous mental health diagnosis per client/medical record: GAD, Unspecified Trauma, PTSD, Stimulant use disorder, ADHD confirmed by school records

Substance Use History

Have you used/abused any of the following (include frequency/amt/last use):

 

Substance Y/N Frequency/Last Use
Tobacco products Y ½
ETOH Y last drink 2 weeks ago, reports drinks 1-2 times monthly one drink socially
Cannabis N
Cocaine Y last use 2015
Prescription stimulants Y last use 2015
Methamphetamine N
Inhalants N
Sedative/sleeping pills N
Hallucinogens N
Street Opioids N
Prescription opioids N
Other: specify (spice, K2, bath salts, etc.) Y reports one-time ecstasy use in 2015

 

Any history of substance related:

  • Blackouts:  +
  • Tremors:   –
  • DUI: –
  • D/T’s: –
  • Seizures: –

Longest sobriety reported since 2015—stayed sober maintaining sponsor, sober friends, and meetings

Psychosocial History

Client was raised by adoptive parents since age 6; from Russian orphanage. She has unknown siblings. She is single; has no children.

Employed at local tanning bed salon

Education: High School Diploma

Denied current legal issues.

Suicide / HOmicide Risk Assessment

RISK FACTORS FOR SUICIDE:

  • Suicidal Ideas or plans – no
  • Suicide gestures in past – no
  • Psychiatric diagnosis – yes
  • Physical Illness (chronic, medical) – no
  • Childhood trauma – yes
  • Cognition not intact – no
  • Support system – yes
  • Unemployment – no
  • Stressful life events – yes
  • Physical abuse – yes
  • Sexual abuse – yes
  • Family history of suicide – unknown
  • Family history of mental illness – unknown
  • Hopelessness – no
  • Gender – female
  • Marital status – single
  • White race
  • Access to means
  • Substance abuse – in remission

 

PROTECTIVE FACTORS FOR SUICIDE:

  • Absence of psychosis – yes
  • Access to adequate health care – yes
  • Advice & help seeking – yes
  • Resourcefulness/Survival skills – yes
  • Children – no
  • Sense of responsibility – yes
  • Pregnancy – no; last menses one week ago, has Norplant
  • Spirituality – yes
  • Life satisfaction – “fair amount”
  • Positive coping skills – yes
  • Positive social support – yes
  • Positive therapeutic relationship – yes
  • Future oriented – yes

 

Suicide Inquiry:

Denies active suicidal ideations, intentions, or plans. Denies recent self-harm behavior. Talks futuristically. Denied history of suicidal/homicidal ideation/gestures; denied history of self-mutilation behaviors

 

Global Suicide Risk Assessment:

The client is found to be at low risk of suicide or violence, however, risk of lethality increased under context of drugs/alcohol.

 

No required SAFETY PLAN related to low risk

Mental Status Examination

She is a 25 yo Russian female who looks her stated age. She is cooperative with examiner. She is neatly groomed and clean, dressed appropriately. There is mild psychomotor restlessness.

Her speech is clear, coherent, normal in volume and tone, has strong cultural accent. Her thought process is ruminative.

There is no evidence of looseness of association or flight of ideas. Her mood is anxious, mildly irritable, and her affect appropriate to her mood. She was smiling at times in an appropriate manner. She denies any auditory or visual hallucinations.

There is no evidence of any delusional thinking. She denies any current suicidal or homicidal ideation. Cognitively, She is alert and oriented to all spheres. Her recent and remote memory is intact. Her concentration is fair. Her insight is good.

Clinical Impression

Client is a 25 yo Russian female who presents with history of treatment for PTSD, ADHD, Stimulant use Disorder, in remission.

Moods are anxious and irritable. She has ongoing reported symptoms of re-experiencing, avoidance, and hyperarousal of her past trauma experiences; ongoing subsyndromal symptoms related to her past ADHD diagnosis and exacerbated by her PTSD diagnosis.

She denied vegetative symptoms of depression, no evident mania/hypomania, no psychosis, denied anxiety symptoms. Denied current cravings for drugs/alcohol, exhibits no withdrawal symptoms, has somatic concerns of GI upset and headaches.

At the time of disposition, the client adamantly denies SI/HI ideations, plans or intent and has the ability to determine right from wrong, and can anticipate the potential consequences of behaviors and actions.

She is a low risk for self-harm based on her current clinical presentation and her risk and protective factors.

Diagnostic Impression

PTSD & ADHD

PTSD:

  • DSM-5 diagnostic code: 309.81 (F43.10) (APA, 2013)
  • ICD-10 code: F43.10 (ICM10Data.com, n.d.-a)

ADHD (combined presentation):

  • DSM-5 code: 314.01 (F90.2) (APA, 2013)
  • ICD-10 code: F90.2 (ICM10Data.com, n.d.-b)

Treatment Plan

1)       Medication:

Increase fluoxetine 40mg po daily for PTSD #30 1 RF

Continue with atomoxetine 80mg po daily for ADHD.  #30 1 RF

Instructed to call and report any adverse reactions.

Future Plan: monitor for decreased re-experiencing, hyperarousal, and avoidance symptoms; monitor for improved concentration, fewer mistakes, less forgetful

 

2)       Education: Risks and benefits of medications are discussed including non-treatment. Potential side effects of medications discussed.

Verbal informed consent was obtained.

Not to drive or operate dangerous machinery if feeling sedated.

Not to stop the medication abruptly without discussing it with providers.

Discussed risks of mixing medications with OTC drugs, herbal, alcohol/illegal drugs. Instructed to avoid this practice. Praised and Encouraged ongoing abstinence. Maintain support system, sponsors, and meetings.

Discussed how drugs/ETOH affects mental health, physical health, sleep architecture.

 

3)       Patient was educated about therapy and services of the MHC including emergent care. Referral was sent via email to therapy team for PET treatment.

 

4)       Patient has emergency numbers: Emergency Services 911, the national Crisis Line 800-273-TALK, the MHC Crisis Clinic. Patient was instructed to go to nearest ER or call 911 if they become actively suicidal and/or homicidal.

 

5)       Time allowed for questions and answers provided. Provided supportive listening. Patient appeared to understand discussion and appears to have capacity for decision making via verbal conversation.

 

6)       RTC in 30 days

 

7)       Follow up with PCP for GI upset and headaches, reviewed PCP history and physical dated one week ago and include lab results

Patient is amenable with this plan and agrees to follow treatment regimen as discussed.

Narrative Answers

 

The ICD-10 coding system is used to classify diseases and aid in billing and payment. According to Leon-Chisen (2018), it stands for the tenth revision of the International Classification of Diseases, Clinical Modification.

The information needed in records to complement DSM-5 and ICD-10 classification usually defines what was done to the client and whether the interventions were provided as an outpatient or inpatient.

It’s worth noting, though, that the DSM-5 helps clinicians diagnose more exactly, whereas the ICD-10 helps them classify and bill for payment much more correctly.

This relevant information is that there must be a match in the DSM-5 and ICD-10 codes, it must be indicated whether the client is an inpatient or an outpatient, the procedure or intervention done must be stated exactly and unambiguously including the amount of time it took to do it, there has to be a maximum of 7 alphanumeric characters in the ICD-10 code, and there must be a provision for clinician query process to find out answers to unclear parts of the billing and coding.

 

The Missing Information According to the resented Case

The following information is missing from the documentation of the case scenario presented:

  1. The age at which the ADHD symptoms first appeared. This is because treatment plans for childhood-onset and adult-onset ADHD may differ (Sadock et al., 2015).
  2. The duration of the patient’s treatment with fluoxetine and atomoxetine. This, too, may have an impact on the treatment approach, as additional medications may be considered if the therapeutic effect is delayed or non-existent.

Given the preceding observation, further information about the length of time the patient will be on therapy in weeks as well as the duration of each session might be valuable in restricting the coding and billing possibilities.

It would also be beneficial to know if the practitioner performed any more testing to get at the diagnosis.

Improving Documentation for Better Coding and Billing

The quest for higher income for both the practitioner and the organization is centered on proper coding and billing. The following are some of the tactics the business can take to improve billing and coding so that reimbursement claims generate more revenue:

  1. Having a designated person whose duty it is to countercheck claims and follow up on any claims that have been denied and need to be resubmitted. This is due to the fact that, as humans, we will occasionally fail to properly document something. When filling out the details in the electronic health record (EHR) system, certain information may have been overlooked.
  2. Keeping up with changes in billing and coding protocols that occur from time to time. This guarantees that the organization’s billing and coding methods are up to date.
  3. Ensuring that any deadlines established by stakeholders, such as payers, are reached on time.
  4. Appointment of a coder to assist physicians with coding so that crucial information required for seamless and better reimbursement is not overlooked. Clinicians, such as physicians, frequently overlook vital information because they believe it is unimportant.
  5. Ascertaining that each patient’s primary and secondary payers are identified.
  6. Verifying benefits before administering any treatment to avoid administering treatment that is not covered, causing the claim to be refused.

 

References

 

American Psychiatric Association [APA] (2013). Diagnostic and Statistical Manual of Mental Disorders (DSM-5), 5th ed. Author.

ICM10Data.com (n.d.-a). Post-traumatic stress disorder, unspecified. https://www.icd10data.com/ICD10CM/Codes/F01-F99/F40-F48/F43-/F43.10

ICM10Data.com (n.d.-b). Attention-deficit hyperactivity disorder, combined type. https://www.icd10data.com/ICD10CM/Codes/F01-F99/F90-F98/F90-/F90.2

Leon-Chisen, N. (2018). ICD-10-CM and ICD-10-PCS coding handbook 2019, revised ed. Health Forum, Inc.

Sadock, B.J., Sadock, V.A., & Ruiz, P. (2015). Synopsis of psychiatry: Behavioral sciences clinical psychiatry, 11th ed. Wolters Kluwer.